| The Global X China Biotech Innovation ETF (CHB) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index. The index is designed to track performance of Chinese companies that are active in the fi eld of Biotechnology. Securities must be listed on one of the following stock exchanges: Hong Kong Stock Exchange (HKSE), Shanghai-Hong Kong Stock Connect, Shenzhen-Hong Kong Stock Connect, New York Stock Exchange (NYSE) and NASDAQ. Eligible securities include H-Shares, Red Chips, P-Chips, A-Shares, ADRs and common stocks with a primary listing on the NYSE or NASDAQ. Each security must be classifi ed as Biotechnology by FactSet Industry. |